 Kelley Colvin
Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 5 | 2023 | 335 | 1.640 |
Why?
| | Hypertension, Pulmonary | 11 | 2021 | 1729 | 1.050 |
Why?
| | Respiratory Tract Infections | 1 | 2023 | 319 | 0.670 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2017 | 56 | 0.530 |
Why?
| | Lymphoid Tissue | 1 | 2013 | 62 | 0.440 |
Why?
| | Blood Vessels | 1 | 2013 | 180 | 0.390 |
Why?
| | Precision Medicine | 1 | 2015 | 337 | 0.380 |
Why?
| | Proteome | 1 | 2015 | 339 | 0.380 |
Why?
| | Lung | 5 | 2023 | 3561 | 0.370 |
Why?
| | Lung Diseases | 1 | 2017 | 701 | 0.350 |
Why?
| | Proteomics | 2 | 2015 | 836 | 0.340 |
Why?
| | Immunoglobulin G | 1 | 2013 | 770 | 0.330 |
Why?
| | Biomarkers | 2 | 2015 | 3408 | 0.300 |
Why?
| | Autoantibodies | 1 | 2013 | 1346 | 0.260 |
Why?
| | Cardiovascular Diseases | 1 | 2017 | 1727 | 0.250 |
Why?
| | Disease Models, Animal | 4 | 2023 | 3535 | 0.220 |
Why?
| | Biology | 1 | 2023 | 79 | 0.200 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2021 | 16 | 0.190 |
Why?
| | Ventricular Function | 1 | 2021 | 57 | 0.180 |
Why?
| | Cytokines | 4 | 2017 | 1841 | 0.180 |
Why?
| | Matrix Metalloproteinases | 1 | 2021 | 89 | 0.180 |
Why?
| | Pulmonary Artery | 4 | 2021 | 1016 | 0.170 |
Why?
| | Prognosis | 2 | 2017 | 3329 | 0.160 |
Why?
| | Interferon-alpha | 1 | 2019 | 186 | 0.150 |
Why?
| | Fibroblasts | 2 | 2013 | 838 | 0.150 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2012 | 351 | 0.140 |
Why?
| | TRPM Cation Channels | 1 | 2017 | 67 | 0.140 |
Why?
| | Vascular Stiffness | 1 | 2021 | 407 | 0.130 |
Why?
| | Cardiovascular System | 1 | 2017 | 125 | 0.120 |
Why?
| | Cause of Death | 1 | 2017 | 361 | 0.120 |
Why?
| | Receptor, Endothelin B | 4 | 2012 | 51 | 0.110 |
Why?
| | Receptors, Endothelin | 2 | 2003 | 49 | 0.100 |
Why?
| | Rats, Wistar | 1 | 2013 | 368 | 0.100 |
Why?
| | Rats | 5 | 2013 | 4958 | 0.100 |
Why?
| | Case-Control Studies | 2 | 2017 | 3003 | 0.100 |
Why?
| | Bronchi | 1 | 2013 | 232 | 0.100 |
Why?
| | Animals | 7 | 2023 | 31706 | 0.100 |
Why?
| | Endothelin-1 | 2 | 2012 | 168 | 0.100 |
Why?
| | Unfolded Protein Response | 1 | 2012 | 43 | 0.100 |
Why?
| | Male | 10 | 2023 | 55599 | 0.100 |
Why?
| | Arteritis | 1 | 2012 | 27 | 0.100 |
Why?
| | Inflammation | 4 | 2017 | 2480 | 0.090 |
Why?
| | Humans | 11 | 2023 | 114689 | 0.090 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2012 | 411 | 0.090 |
Why?
| | Phagocytes | 1 | 2011 | 90 | 0.090 |
Why?
| | Inflammation Mediators | 1 | 2013 | 477 | 0.090 |
Why?
| | Dendritic Cells | 1 | 2013 | 435 | 0.090 |
Why?
| | Heart Defects, Congenital | 1 | 2017 | 671 | 0.090 |
Why?
| | Myeloid Cells | 1 | 2011 | 126 | 0.090 |
Why?
| | Mesoderm | 1 | 2011 | 138 | 0.090 |
Why?
| | Blood Proteins | 1 | 2012 | 231 | 0.090 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2012 | 236 | 0.080 |
Why?
| | Mice | 2 | 2023 | 14869 | 0.080 |
Why?
| | Phenotype | 1 | 2017 | 2796 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2086 | 0.080 |
Why?
| | Female | 9 | 2023 | 59511 | 0.070 |
Why?
| | Autoimmunity | 1 | 2013 | 813 | 0.070 |
Why?
| | Gene Expression Profiling | 1 | 2013 | 1518 | 0.070 |
Why?
| | Flow Cytometry | 3 | 2019 | 1083 | 0.070 |
Why?
| | Tunica Intima | 1 | 2005 | 78 | 0.060 |
Why?
| | Arterial Occlusive Diseases | 1 | 2005 | 74 | 0.060 |
Why?
| | Risk Factors | 1 | 2017 | 8632 | 0.060 |
Why?
| | Endothelial Growth Factors | 1 | 2003 | 50 | 0.050 |
Why?
| | Lymphokines | 1 | 2003 | 111 | 0.050 |
Why?
| | Pulmonary Edema | 1 | 2003 | 115 | 0.050 |
Why?
| | Chemokine CCL2 | 2 | 2012 | 105 | 0.050 |
Why?
| | Child | 6 | 2021 | 18415 | 0.050 |
Why?
| | Arterial Pressure | 1 | 2021 | 99 | 0.040 |
Why?
| | Adolescent | 5 | 2021 | 17848 | 0.040 |
Why?
| | Hypoxia | 2 | 2003 | 958 | 0.040 |
Why?
| | Animals, Genetically Modified | 3 | 2005 | 216 | 0.040 |
Why?
| | Receptor, Endothelin A | 2 | 2012 | 60 | 0.040 |
Why?
| | Hypertension | 1 | 2005 | 1056 | 0.040 |
Why?
| | Listeriosis | 1 | 2017 | 61 | 0.040 |
Why?
| | Hemodynamics | 1 | 2021 | 1012 | 0.030 |
Why?
| | Listeria monocytogenes | 1 | 2017 | 111 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2012 | 498 | 0.030 |
Why?
| | Atrial Natriuretic Factor | 1 | 2015 | 55 | 0.030 |
Why?
| | Infant | 3 | 2012 | 7963 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 531 | 0.030 |
Why?
| | Breath Tests | 1 | 2015 | 82 | 0.030 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2015 | 94 | 0.030 |
Why?
| | Child, Preschool | 3 | 2012 | 9116 | 0.030 |
Why?
| | Cell-Derived Microparticles | 1 | 2015 | 57 | 0.030 |
Why?
| | Vascular Remodeling | 1 | 2015 | 153 | 0.030 |
Why?
| | Endothelins | 2 | 2003 | 61 | 0.030 |
Why?
| | Echocardiography | 1 | 2015 | 553 | 0.030 |
Why?
| | Regulatory Factor X Transcription Factors | 1 | 2012 | 9 | 0.020 |
Why?
| | Activating Transcription Factor 6 | 1 | 2012 | 16 | 0.020 |
Why?
| | Endothelin A Receptor Antagonists | 1 | 2012 | 24 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2017 | 720 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 2570 | 0.020 |
Why?
| | Leukocyte Common Antigens | 1 | 2011 | 75 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 146 | 0.020 |
Why?
| | Peptide Fragments | 1 | 2015 | 666 | 0.020 |
Why?
| | Chemokine CXCL12 | 1 | 2011 | 74 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 164 | 0.020 |
Why?
| | Cell Count | 1 | 2011 | 303 | 0.020 |
Why?
| | Immunomodulation | 1 | 2011 | 84 | 0.020 |
Why?
| | Interleukin-10 | 1 | 2012 | 299 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2011 | 397 | 0.020 |
Why?
| | Transcription Factors | 2 | 2012 | 1528 | 0.020 |
Why?
| | Vasodilator Agents | 1 | 2012 | 302 | 0.020 |
Why?
| | Cell Separation | 1 | 2011 | 291 | 0.020 |
Why?
| | Endothelial Cells | 1 | 2015 | 687 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 797 | 0.020 |
Why?
| | Hyaluronic Acid | 1 | 2012 | 190 | 0.020 |
Why?
| | Adult | 3 | 2019 | 30550 | 0.020 |
Why?
| | Arrhythmias, Cardiac | 1 | 2011 | 279 | 0.020 |
Why?
| | MicroRNAs | 1 | 2015 | 600 | 0.020 |
Why?
| | Monocytes | 1 | 2012 | 504 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2012 | 676 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 993 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2017 | 4694 | 0.020 |
Why?
| | Cardiac Catheterization | 1 | 2011 | 534 | 0.020 |
Why?
| | Phosphorylation | 1 | 2012 | 1569 | 0.020 |
Why?
| | Stem Cells | 1 | 2011 | 546 | 0.020 |
Why?
| | Young Adult | 2 | 2011 | 10470 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2015 | 2286 | 0.020 |
Why?
| | Monocrotaline | 1 | 2005 | 26 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2012 | 1314 | 0.020 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2005 | 141 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3053 | 0.010 |
Why?
| | Rats, Mutant Strains | 1 | 2003 | 25 | 0.010 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2003 | 61 | 0.010 |
Why?
| | Endothelin Receptor Antagonists | 1 | 2003 | 58 | 0.010 |
Why?
| | Isoxazoles | 1 | 2003 | 51 | 0.010 |
Why?
| | Capillary Permeability | 1 | 2003 | 139 | 0.010 |
Why?
| | Thiophenes | 1 | 2003 | 108 | 0.010 |
Why?
| | 6-Ketoprostaglandin F1 alpha | 1 | 2002 | 21 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2012 | 5047 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2002 | 193 | 0.010 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2002 | 57 | 0.010 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2003 | 249 | 0.010 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2002 | 108 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2002 | 292 | 0.010 |
Why?
| | Disease Susceptibility | 1 | 2003 | 316 | 0.010 |
Why?
| | Protein Precursors | 1 | 2002 | 119 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 2002 | 209 | 0.010 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2002 | 184 | 0.010 |
Why?
| | Epoprostenol | 1 | 2002 | 133 | 0.010 |
Why?
| | Blotting, Western | 1 | 2003 | 1147 | 0.010 |
Why?
| | Pulmonary Circulation | 1 | 2002 | 407 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 26737 | 0.010 |
Why?
| | Signal Transduction | 1 | 2012 | 4513 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2012 | 9088 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2005 | 2187 | 0.010 |
Why?
| | Gene Expression | 1 | 2002 | 1421 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2002 | 823 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2002 | 2553 | 0.010 |
Why?
|
|
Colvin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|